These observations are likely to prove relevant to several other cancers in which ARHI is downregulated, including breast, lung, prostate, pancreatic, hepatic and thyroid cancers.46, 47, 48, 49. This evidence concerns the gene DIRAS3 and thyroid gland carcinoma.